Dexamethasone Sodium Phosphate Injection, Solution
Product Images NDC 51662-1370

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Dexamethasone Sodium Phosphate (NDC 51662-1370). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Dosage 1 (Dosage 1)

A data table listing dosages by various authors for intravenous injection of dexamethasone sodium phosphate. The table includes author names and corresponding dosage recommendations, such as 3 mg/kg per 24 hours by constant infusion, 2 to 6 mg/kg as a single injection, and repeat doses of 40 mg every 2 to 6 hours under certain conditions. The table presents comparative dosing information from five different sources.*

FDA Label Image

Dosage 2 (Dosage 2)

A table showing recommended amounts of dexamethasone phosphate in milligrams for injection at various sites, including large joints (2 to 4 mg), small joints (0.8 to 1 mg), bursae (2 to 3 mg), tendon sheaths (0.4 to 1 mg), soft tissue infiltration (2 to 6 mg), and ganglia (1 to 2 mg).*

FDA Label Image

How Suplied (How Supplied)

A table listing three Dexamethasone Sodium Phosphate Injection USP products with varying volumes and concentrations: 1 mL fill in a 2 mL flip-top vial (NDC 63323-165-01), 5 mL fill in a 5 mL flip-top vial (NDC 63323-165-05), and 30 mL fill in a 30 mL flip-top vial (NDC 63323-165-30). Each contains 4 mg/mL dexamethasone phosphate, packaged in different quantities.*

FDA Label Image

Logo (Logo)

FDA Label Image

Serialized Vial Labeling (Serialized Vial Labeling)

Dexamethasone Sodium Phosphate injection, USP, 4 mg/mL (20 mg per 5 mL) in a 5 mL multiple dose vial. The vial has a brown glass body with a blue cap and a label indicating use for intramuscular or intravenous injection. The labeler is HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Structure (Structure)

Chemical structure of dexamethasone sodium phosphate with molecular formula C22H28FNa2O8P and molecular weight 516.41, showing its steroid backbone and phosphate groups.*

FDA Label Image

Vial 1 (Vial 1)

Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL (20 mg per 5 mL) in a 5 mL multiple dose amber glass vial. The vial has a blue cap and is labeled for intramuscular or intravenous use. The product is prescription only (Rx) and produced by HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Vial 2 (Vial 2)

Dexamethasone Sodium Phosphate 4 mg/mL injection solution in a small amber glass vial with a blue flip-off cap. The label includes storage instructions to keep at 20° to 25°C (68° to 77°F), protect from heat and light, and a note to see the package insert for usual dosage. Labeler is HF Acquisition Co LLC, DBA HealthFirst.*

FDA Label Image

Vial 3 (Vial 3)

Amber glass vial with a blue cap containing Dexamethasone Sodium Phosphate injection, solution. The visible label section includes a lot number, expiration date, and a barcode. The full product details, including strength and manufacturer, are not fully visible in the image.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.